161 related articles for article (PubMed ID: 31578584)
1. High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
Negri F; Bozzetti C; Pedrazzi G; Azzoni C; Bottarelli L; Squadrilli A; Lagrasta C; Tamagnini I; Bisagni A; Ragazzi M; Porzio R; Tomasello G; Mori D; Leonardi F; Gnetti L; Crafa P; Sala R; Cascinu S
Oncol Rep; 2019 Dec; 42(6):2750-2758. PubMed ID: 31578584
[TBL] [Abstract][Full Text] [Related]
2. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
[TBL] [Abstract][Full Text] [Related]
3. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.
Harjes U; Bridges E; McIntyre A; Fielding BA; Harris AL
J Biol Chem; 2014 Aug; 289(33):23168-23176. PubMed ID: 24939870
[TBL] [Abstract][Full Text] [Related]
5. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
Jubb AM; Turley H; Moeller HC; Steers G; Han C; Li JL; Leek R; Tan EY; Singh B; Mortensen NJ; Noguera-Troise I; Pezzella F; Gatter KC; Thurston G; Fox SB; Harris AL
Br J Cancer; 2009 Nov; 101(10):1749-57. PubMed ID: 19844231
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
7. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
8. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.
Yen WC; Fischer MM; Hynes M; Wu J; Kim E; Beviglia L; Yeung VP; Song X; Kapoun AM; Lewicki J; Gurney A; Simeone DM; Hoey T
Clin Cancer Res; 2012 Oct; 18(19):5374-86. PubMed ID: 22952347
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A.
Burgermeister E; Battaglin F; Eladly F; Wu W; Herweck F; Schulte N; Betge J; Härtel N; Kather JN; Weis CA; Gaiser T; Marx A; Weiss C; Hofheinz R; Miller IS; Loupakis F; Lenz HJ; Byrne AT; Ebert MP
EBioMedicine; 2019 Jul; 45():139-154. PubMed ID: 31300350
[TBL] [Abstract][Full Text] [Related]
10. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
Zhang Y; Zhang Y; Wang J; Gu H
Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
[TBL] [Abstract][Full Text] [Related]
11. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G
Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099
[TBL] [Abstract][Full Text] [Related]
12. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
13. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
[TBL] [Abstract][Full Text] [Related]
14. Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.
Zhao M; Yu Z; Li Z; Tang J; Lai X; Liu L
Oncol Rep; 2017 Jan; 37(1):601-607. PubMed ID: 27840995
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer.
Li J; Han R; Li J; Zhai L; Xie X; Zhang J; Chen Y; Luo J; Wang S; Sun Z; Cao Y; Lin L; Yang Q
Biomed Res Int; 2021; 2021():8875503. PubMed ID: 33628824
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.
Paiva TF; de Jesus VH; Marques RA; da Costa AA; de Macedo MP; Peresi PM; Damascena A; Rossi BM; Begnami MD; de Lima VC
BMC Cancer; 2015 Sep; 15():643. PubMed ID: 26394830
[TBL] [Abstract][Full Text] [Related]
17. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
[TBL] [Abstract][Full Text] [Related]
18. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
Chang PH; Sekine K; Chao HM; Hsu SH; Chern E
Sci Rep; 2017 Apr; 8():45751. PubMed ID: 28367998
[TBL] [Abstract][Full Text] [Related]
19. Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells.
Apostolou P; Toloudi M; Ioannou E; Kourtidou E; Chatziioannou M; Kopic A; Komiotis D; Kiritsis C; Manta S; Papasotiriou I
J Recept Signal Transduct Res; 2013 Dec; 33(6):353-8. PubMed ID: 23964856
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
